May 10, 2022
PAR-20-111 - Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-20-111 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)". This Funding Opportunity Announcement (FOA) has been extended to add a new application due date of August 9, 2023 and an AIDS application due date of September 7, 2023.
Currently Reads:
Part 1. Overview Information
Key Dates:
|
August 11, 2020, February 9, 2021,August 10, 2021,February 9, 2022,August 9, 2022, February 9, 2023 by 5:00 PM local time of applicant organization. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
|
September 7, 2020,May 7, 2021,September 7, 2021, May 7, 2022, September 7, 2022, May 7, 2023 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
| November 2020, June 2021, November 2021, June 2022, November 2022, June 2023, |
| January 2021, October 2021, January 2022, October 2022, January 2023, October 2023 |
| May 08, 2023 |
Modified to Read:
Part 1. Overview Information
Key Dates:
|
August 11, 2020, February 9, 2021,August 10, 2021,February 9, 2022,August 9, 2022, February 9, 2023, August 9, 2023 by 5:00 PM local time of applicant organization. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
|
September 7, 2020,May 7, 2021,September 7, 2021, May 7, 2022, September 7, 2022, May 7, 2023, September 7, 2023 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
| November 2020, June 2021, November 2021, June 2022, November 2022, June 2023, November 2023 |
| January 2021, October 2021, January 2022, October 2022, January 2023, October 2023, January 2024 |
| September 8, 2023 |
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
All other aspects of this FOA remain unchanged.
Charles Cywin, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: charles.cywin@nih.gov
and Human Services (HHS)
